Elaine Castellanos - 26 May 2021 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role
VP, Chief Accounting Officer
Signature
/s/ Tracy Herson, attorney-in-fact
Issuer symbol
N/A
Transactions as of
26 May 2021
Net transactions value
-$1,053,716
Form type
4
Filing time
27 May 2021, 18:15:17 UTC
Next filing
09 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Conversion of derivative security +10,000 +69% 24,546 26 May 2021 Direct F1
transaction RETA Class A common stock Sale $1,245,470 -10,000 -41% $124.55 14,546 26 May 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Employee Stock Option (right to buy) Options Exercise $0 -2,934 -100% $0.000000* 0 26 May 2021 Class B common stock 2,934 $11.00 Direct F1, F3
transaction RETA Employee Stock Option (right to buy) Options Exercise $0 -7,066 -26% $0.000000 19,934 26 May 2021 Class B common stock 7,066 $22.57 Direct F1, F4
transaction RETA Class B common stock Options Exercise $32,274 +2,934 $11.00 2,934 26 May 2021 Class A common stock 2,934 Direct F1
transaction RETA Class B common stock Options Exercise $159,480 +7,066 +241% $22.57 10,000 26 May 2021 Class A common stock 7,066 Direct F1
transaction RETA Class B common stock Conversion of derivative security -10,000 -100% 0 26 May 2021 Class A common stock 10,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $124.36 to $124.95. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The options vested in sixteen equal quarterly installments beginning on August 25, 2016.
F4 The options vest in twenty equal quarterly installments beginning on March 7, 2017, subject to continued service through each vesting date.